201 related articles for article (PubMed ID: 31937733)
41. The ORNATE India Project: United Kingdom-India Research Collaboration to tackle visual impairment due to diabetic retinopathy.
Sivaprasad S; Raman R; Conroy D; Mohan ; Wittenberg R; Rajalakshmi R; Majeed A; Krishnakumar S; Prevost T; Parameswaran S; Turowski P; Maheswari U; Khobragade R; Netuveli G; Sadanandan R; Greenwood J; Ramasamy K; Rao M; Bergeles C; Das T;
Eye (Lond); 2020 Jul; 34(7):1279-1286. PubMed ID: 32398841
[TBL] [Abstract][Full Text] [Related]
42. Diabetic retinopathy (DR) among 40 years and older Saudi population with diabetes in Riyadh governorate, Saudi Arabia - A population based survey.
Yasir ZH; Hassan AD; Rajiv K
Saudi J Ophthalmol; 2019; 33(4):363-368. PubMed ID: 31920446
[TBL] [Abstract][Full Text] [Related]
43. Availability and variability in guidelines on diabetic retinopathy screening in Asian countries.
Wang LZ; Cheung CY; Tapp RJ; Hamzah H; Tan G; Ting D; Lamoureux E; Wong TY
Br J Ophthalmol; 2017 Oct; 101(10):1352-1360. PubMed ID: 28292772
[TBL] [Abstract][Full Text] [Related]
44. The economic burden of diabetic retinopathy care at a tertiary eye care center in South India.
Orji A; Rani PK; Narayanan R; Sahoo NK; Das T
Indian J Ophthalmol; 2021 Mar; 69(3):666-670. PubMed ID: 33595498
[TBL] [Abstract][Full Text] [Related]
45. Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis.
Xie J; Ikram MK; Cotch MF; Klein B; Varma R; Shaw JE; Klein R; Mitchell P; Lamoureux EL; Wong TY
JAMA Ophthalmol; 2017 Jun; 135(6):586-593. PubMed ID: 28472362
[TBL] [Abstract][Full Text] [Related]
46. Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real-world observational analysis of a health claims database.
Kawasaki R; Konta T; Nishida K
Diabetes Obes Metab; 2018 Oct; 20(10):2351-2360. PubMed ID: 29790265
[TBL] [Abstract][Full Text] [Related]
47. Association of mean ocular perfusion pressure and diabetic retinopathy in type 2 diabetes mellitus: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS, Report 28).
Raman R; Gupta A; Kulothungan V; Sharma T
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4592-7. PubMed ID: 21546536
[TBL] [Abstract][Full Text] [Related]
48. Magnitude and determinants of ocular morbidities among persons with diabetes in a project in Ahmedabad, India.
Vyas U; Khandekar R; Trivedi N; Desai T; Danayak P
Diabetes Technol Ther; 2009 Sep; 11(9):601-7. PubMed ID: 19764840
[TBL] [Abstract][Full Text] [Related]
49. Medical management for the prevention and treatment of diabetic macular edema.
Kiire CA; Porta M; Chong V
Surv Ophthalmol; 2013; 58(5):459-65. PubMed ID: 23969020
[TBL] [Abstract][Full Text] [Related]
50. Diabetic retinopathy screening in the public sector in India: What is needed?
Gupta V; Azad SV; Vashist P; Senjam SS; Kumar A
Indian J Ophthalmol; 2022 Mar; 70(3):759-767. PubMed ID: 35225509
[TBL] [Abstract][Full Text] [Related]
51. Pharmacologic therapies for diabetic retinopathy and diabetic macular edema.
Rechtman E; Harris A; Garzozi HJ; Ciulla TA
Clin Ophthalmol; 2007 Dec; 1(4):383-91. PubMed ID: 19668515
[TBL] [Abstract][Full Text] [Related]
52. Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.
Fenwick EK; Xie J; Pesudovs K; Ratcliffe J; Chiang PP; Finger RP; Lamoureux EL
Clin Exp Optom; 2012 May; 95(3):362-70. PubMed ID: 22537275
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of predictive risk models for sight threatening diabetic retinopathy in patients with type 2 diabetes to be applied as triage tools in resource limited settings.
Nugawela MD; Gurudas S; Prevost AT; Mathur R; Robson J; Sathish T; Rafferty JM; Rajalakshmi R; Anjana RM; Jebarani S; Mohan V; Owens DR; Sivaprasad S
EClinicalMedicine; 2022 Sep; 51():101578. PubMed ID: 35898318
[TBL] [Abstract][Full Text] [Related]
54. The Diabetic Retinopathy Barometer Study: Global perspectives on access to and experiences of diabetic retinopathy screening and treatment.
Cavan D; Makaroff L; da Rocha Fernandes J; Sylvanowicz M; Ackland P; Conlon J; Chaney D; Malhi A; Barratt J
Diabetes Res Clin Pract; 2017 Jul; 129():16-24. PubMed ID: 28499163
[TBL] [Abstract][Full Text] [Related]
55. A Retrieval System for Patients with Avoidable Blindness Due to Diabetic Retinopathy who do not Present for Ophthalmic Assessment in Oman.
Khandekar R; Al Lawati J; Barakat N
Middle East Afr J Ophthalmol; 2011 Apr; 18(2):93-7. PubMed ID: 21731317
[TBL] [Abstract][Full Text] [Related]
56. Diabetic care initiatives to prevent blindness from diabetic retinopathy in India.
Murthy GV; Das T
Indian J Ophthalmol; 2016 Jan; 64(1):50-4. PubMed ID: 26953024
[TBL] [Abstract][Full Text] [Related]
57. Diabetic retinopathy and ocular co-morbidities among persons with diabetes at Sumail Hospital of Oman.
Khandekar RB; Tirumurthy S; Al-Harby S; Moorthy NS; Amir I
Diabetes Technol Ther; 2009 Oct; 11(10):675-9. PubMed ID: 19821761
[TBL] [Abstract][Full Text] [Related]
58. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
Lee R; Wong TY; Sabanayagam C
Eye Vis (Lond); 2015; 2():17. PubMed ID: 26605370
[TBL] [Abstract][Full Text] [Related]
59. The status of diabetic retinopathy and diabetic macular edema in patients with type 2 diabetes: a survey from Beixinjing District of Shanghai city in China.
Wang N; Xu X; Zou H; Zhu J; Wang W; Ho PC
Ophthalmologica; 2008; 222(1):32-6. PubMed ID: 18097178
[TBL] [Abstract][Full Text] [Related]
60. Association of serum adiponectin with diabetic microvascular complications among south Indian type 2 diabetic subjects - (CURES-133).
Pradeepa R; Surendar J; Indulekha K; Chella S; Anjana RM; Mohan V
Clin Biochem; 2015 Jan; 48(1-2):33-8. PubMed ID: 25445230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
